H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Census population 292,449. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Jersey City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Jersey City storefront.
Extracellular Matrix (ECM) Therapy in Jersey City, NJ for clinics & physicians. ECM therapy products provi… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Jersey City is JL (Novitas Solutions) and that adult diabetes here is 9.6% (PLACES 2023), it is selling units, not a program. That is the extracellular matrix therapy conversation we actually have.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)New Jersey shares JL with DC, DE, MD, PA. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Jersey City trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 9.6% of adults — 2.4 points below the U.S. 12% figure. Obesity is 26.2%; arthritis is 14.6%. That is place-level BRFSS modeling, not a clinic census and not a Jersey City trial.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Novitas Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Regulatory lane, storage, and JL coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Bring specialty, monthly joint / regenerative volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.6% diabetes and 14.6% arthritis for Jersey City — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Jersey City, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Jersey City is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Jersey City — 2.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Jersey City. Useful for joint-program math; still needs a diagnosis and privileging.
No Jersey City storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.